Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Buchanan: Preservation of pancreatic β-cell function and prevention of type 2 diabetes by.... (0.10 sec) 

Preservation of pancreatic β-cell function and prevention of type 2 diabetes by …

- diabetesjournals.org
TA Buchanan, AH Xiang, RK Peters, SL Kjos, … - Diabetes, 2002 - Am Diabetes Assoc
Type 2 diabetes frequently results from progressive failure of pancreatic
β-cell function in the presence of chronic insulin resistance. We tested
whether chronic amelioration of insulin resistance would preserve ...
Cited by 921 - Related articles - BL Direct - All 6 versions

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial


JL Chiasson, RG Josse, R Gomis, M Hanefeld, … - The Lancet, 2002 - Elsevier
We randomly allocated 714 patients with impaired glucose tolerance to acarbose
and 715 to placebo. We excluded 61 (4%) patients because they did not have
impaired glucose tolerance or had no postrandomisation data. 211 (31%) of ...
Cited by 1210 - Related articles - All 14 versions

Xenical in the prevention of diabetes in obese subjects (XENDOS) study

- nfff.no [PDF]  - Free from Publisher
JS Torgerson, J Hauptman, MN Boldrin, L … - Diabetes Care, 2004 - Am Diabetes Assoc
RESULTS—Of orlistat-treated patients, 52% completed treatment compared with
34% of placebo recipients (P < 0.0001). After 4 years' treatment, the cumulative
incidence of diabetes was 9.0% with placebo and 6.2% with orlistat, ...
Cited by 728 - Related articles - BL Direct - All 10 versions

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance …


XR Pan, GW Li, YH Hu, JX Wang, WY Yang, ZX … - Diabetes care, 1997 - Am Diabetes Assoc
OBJECTIVE: Individuals with impaired glucose tolerance (IGT) have a high risk of
developing NIDDM. The purpose of this study was to determine whether diet and
exercise interventions in those with IGT may delay the development of ...
Cited by 2001 - Related articles - BL Direct - All 8 versions

Effect of pioglitazone on pancreatic β-cell function and diabetes risk in Hispanic women with …

- nih.gov
AH Xiang, RK Peters, SL Kjos, A Marroquin, … - Diabetes, 2006 - Am Diabetes Assoc
The Pioglitazone In Prevention Of Diabetes (PIPOD) study was conducted to
evaluate β-cell function, insulin resistance, and the incidence of diabetes
during treatment with pioglitazone in Hispanic women with prior gestational ...
Cited by 144 - Related articles - BL Direct - All 13 versions

Pharmacological Treatment of Insulin Resistance at Two Different Stages in the Evolution …

- endojournals.org
AH Xiang, RK Peters, SL Kjos, J Goico, C … - Journal of Clinical Endocrinology & Metabolism, 2004 - Endocrine Soc
During a mean follow-up of 4.3 yr between baseline and posttrial tests, glucose
tolerance (oral glucose tolerance test glucose area, P = 0.04) and insulin
resistance (MINMOD S I , P = 0.02) worsened more in women randomized to ...
Cited by 31 - Related articles - BL Direct - All 6 versions

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired …

- ops.org.ar [PDF] 
J Tuomilehto, J Lindstrom, JG Eriksson, TT … - The New England Journal of Medicine, 2001 - nejm.highwire.org
N Engl J Med, Vol. 344, No. 18 · May 3, 2001 · www.nejm.org · ... PREVENTION
OF TYPE 2 DIABETES MELLITUS BY CHANGES IN LIFESTYLE AMONG SUBJECTS WITH IMPAIRED
GLUCOSE TOLERANCE ... J AAKKO T UOMILEHTO , MD, P H .D., J AANA L ...
Cited by 3747 - Related articles - BL Direct - All 25 versions

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.


KWCBCE Fowler, SEHRFLJM Walker, EAN … - The New England Journal of Medicine, 2002 - 万方数据资源系统
BACKGROUND: Type 2 diabetes affects approximately 8 percent of adults in the
United States. Some risk factors--elevated plasma glucose concentrations in the
fasting state and after an oral glucose load, overweight, and a sedentary ...
Cited by 4245 - Related articles - All 4 versions

Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program.


WC Knowler, RF Hamman, SL Edelstein, E … - Diabetes, 2005 - ncbi.nlm.nih.gov
The Diabetes Prevention Program (DPP) was a randomized clinical trial of
prevention of type 2 diabetes in high-risk people. Troglitazone, an
insulin-sensitizing agent, was used initially but was discontinued during ...
Cited by 144 - Related articles

Ramipril and the development of diabetes


S Yusuf, H Gerstein, B Hoogwerf, J Pogue, J … - Jama, 2001 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Type 2 diabetes ...
Cited by 449 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google